TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Promega Biotech AB
Closing information (x1000 EUR)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
10,672
|
8,414
|
7,791 |
| Financial expenses |
3
|
0
|
0 |
| Earnings before taxes |
867
|
1,153
|
1,118 |
| EBITDA |
874
|
1,160
|
1,133 |
| Total assets |
4,570
|
3,196
|
3,788 |
| Current assets |
4,554
|
3,183
|
3,769 |
| Current liabilities |
1,725
|
1,169
|
897 |
| Equity capital |
2,557
|
1,765
|
2,654 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
10
|
10
|
10 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
56.0%
|
55.2%
|
70.1% |
| Turnover per employee |
1,067
|
841
|
779 |
| Profit as a percentage of turnover |
8.1%
|
13.7%
|
14.3% |
| Return on assets (ROA) |
19.0%
|
36.1%
|
29.5% |
| Current ratio |
264.0%
|
272.3%
|
420.2% |
| Return on equity (ROE) |
33.9%
|
65.3%
|
42.1% |
| Change turnover |
1,734
|
791
|
408 |
| Change turnover % |
19%
|
10%
|
6% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.